Today: 7 February 2026
Subscribe
Browse Category

Investment Analysis News 14 January 2026

Eli Lilly stock slips as FDA drops suicide warning for Zepbound; traders eye orforglipron, earnings next

Eli Lilly stock slips as FDA drops suicide warning for Zepbound; traders eye orforglipron, earnings next

New York, Jan 14, 2026, 11:40 AM EST — Regular session Eli Lilly and Company shares slipped Wednesday following a move by U.S. regulators to remove suicide-related warnings from several popular obesity drugs, including Lilly’s Zepbound. The stock was down roughly 0.4%, trading near $1,072.89 by late morning. (U.S. Food and Drug Administration) The label change is significant because it addresses a major safety concern that’s been dogging weight-loss drugs, even as demand remains robust and politicians and insurers press on prices. For Lilly, obesity remains the key driver in the stock, and anything that cuts “headline risk” usually gets
14 January 2026
·····
Intel stock steadies after KeyBanc upgrade sparks AI-server demand debate

Intel stock steadies after KeyBanc upgrade sparks AI-server demand debate

New York, January 14, 2026, 10:28 AM EST — Regular session Intel shares climbed 1.4% to $47.94 on Wednesday, retreating slightly from an earlier surge but holding steady after a big jump the previous day. So far, the stock has fluctuated between $47.56 and $49.41 during the session. KeyBanc upgraded Intel to “overweight,” signaling the firm expects it to outperform peers, citing stronger-than-anticipated demand for server CPUs—the chips powering data centers. The broker also raised Advanced Micro Devices, noting that both companies seem “largely sold out” of their expected 2026 capacity and could boost prices by 10% to 15%. (Investopedia)
14 January 2026
·····
Natural Gas Services Group stock is back on the analyst tape — what to watch for NGS next

Natural Gas Services Group stock is back on the analyst tape — what to watch for NGS next

New York, Jan 14, 2026, 10:22 ET — Regular session. Shares of Natural Gas Services Group edged up roughly 0.2% to $34.26 Wednesday morning, despite recent downgrades from analysts at Zacks and Raymond James over the last two days. The timing is key since the stock has hovered close to its one-year peak. The recent calls underline a common friction: solid operational momentum against a price that’s already pushed higher. Zacks downgraded its rating from “strong-buy” to “hold,” MarketBeat reported. (MarketBeat) On Tuesday, Raymond James shifted gears with Natural Gas Services Group, cutting its rating to “outperform” from “strong buy”
14 January 2026
·····
Gelteq Limited stock jumps in premarket after CBD gel study; what’s next for GELS

Gelteq Limited stock jumps in premarket after CBD gel study; what’s next for GELS

NEW YORK, Jan 14, 2026, 08:42 AM EST — Premarket Gelteq Limited shares surged roughly 48% to $1.23 in premarket action Wednesday, following a 6.4% gain at Tuesday’s close. (StockAnalysis) The Nasdaq-listed biotech revealed that a recent preclinical study demonstrated its ingestible gel delivery platform boosts cannabidiol (CBD) absorption over an FDA-approved oil-based option. Gelteq also indicated these findings might accelerate plans for a medicinal cannabis launch in Australia. (Gelteq Limited) This is significant as the company relies on Australia’s Special Access Scheme, which lets health practitioners obtain “unapproved” therapeutic goods for individual patients via specific channels. According to the
14 January 2026
····
Progressive stock steadies premarket after 5% slide as Mizuho trims target again

Progressive stock steadies premarket after 5% slide as Mizuho trims target again

New York, January 14, 2026, 09:06 EST — Premarket Shares of The Progressive Corporation (PGR) ticked up 0.2% to $205.44 in Wednesday’s premarket, rebounding slightly after falling 5.3% the day before. Mizuho trimmed its price target on the U.S. insurer to $240 from $242 but maintained a Neutral rating. The quick reset is crucial as insurers head into a packed earnings season, where investors zero in on two key factors: the stability of pricing and the trajectory of claims costs. Even minor changes in rates and loss costs can quickly swing results, especially for personal auto carriers. Wells Fargo cut
14 January 2026
····
Bank of America stock: BAC dips premarket after Q4 beat as interest-income outlook takes center stage

Bank of America stock: BAC dips premarket after Q4 beat as interest-income outlook takes center stage

New York, January 14, 2026, 08:41 EST — Premarket update. Bank of America (BAC) slipped 1.2% in premarket action Wednesday, trading at $54.54, below Tuesday’s close of $55.22. Bank of America delivered a fourth-quarter profit that outpaced Wall Street’s estimates and maintained its forecast for higher net interest income this year. The lender posted net income of $7.6 billion, or 98 cents per share, surpassing the 96 cents per share analysts had anticipated, according to LSEG data. It also projected a 7% increase in first-quarter net interest income and reaffirmed its 5% to 7% growth outlook for fiscal 2026. (Reuters)
14 January 2026
····
Figma stock (FIG) dips in premarket after 8% slide as Goldman Sachs starts coverage

Figma stock (FIG) dips in premarket after 8% slide as Goldman Sachs starts coverage

NEW YORK, Jan 14, 2026, 05:56 (ET) — Premarket Figma (FIG.N) shares slipped 0.1% to $33.52 in early trading Wednesday, after dropping 7.8% to $33.56 on Tuesday. Volume surged to 14.27 million shares, nearly twice its typical daily average. The stock remains close to a 52-week low of $32.83. (Investing.com) The swing is crucial since FIG remains in price discovery post its 2025 IPO, facing fresh coverage and emerging “AI” spending themes amid a shareholder base that’s still in flux. In this environment, even minor headlines can pack more punch than they would for a more established software company. Goldman
14 January 2026
···
GSK stock ticks up after Summit cancer-trial tie-up — what investors watch next

GSK stock ticks up after Summit cancer-trial tie-up — what investors watch next

London, Jan 14, 2026, 09:03 GMT — Regular session GSK shares rose in early London trade on Wednesday after Summit Therapeutics said it struck a clinical trial collaboration with the British drugmaker to test a new cancer combination. (MarketScreener) The move lands as investors look for signposts on how much growth GSK can squeeze from its oncology pipeline before it reports full-year results next month. GSK has pencilled in Feb. 4 for its full-year and fourth-quarter update. (GSK) Big drugmakers have been under pressure to refill pipelines as a wave of patent expiries looms for the industry, helping drive a
14 January 2026
······
BAE Systems stock: Deutsche Bank downgrade puts shipbuilding margins back in focus

BAE Systems stock: Deutsche Bank downgrade puts shipbuilding margins back in focus

London, Jan 14, 2026, 08:18 GMT — Regular session BAE Systems (BAES.L) shares edged up slightly in early London trading Wednesday, finding some footing after Deutsche Bank downgraded the stock, citing challenges in the Maritime division. By 0802 GMT, the stock was 0.34% higher at 2,079 pence, following a close of 2,072 pence. Over the past year, the shares have reached a peak of 2,119 pence. (shareprices.com) This broker call hits home as BAE has regained its momentum stock status, and its valuation reflects that. Now, even a slight slip in margins could inflict more harm than any major contract
14 January 2026
·····
Yangzijiang Shipbuilding shares slide as YZJ Maritime orders 16 vessels, eyes turn to next results

Yangzijiang Shipbuilding shares slide as YZJ Maritime orders 16 vessels, eyes turn to next results

Singapore, Jan 14, 2026, 15:00 SGT — Regular session Shares of Singapore-listed Yangzijiang Shipbuilding (Holdings) Ltd were down 1.9% at S$3.67 on Wednesday, trimming earlier gains as shipbuilding-linked names turned choppy in afternoon trade. The stock is up about 5% so far this year. (marketscreener.com) The move matters because newbuilding activity is one of the cleanest signals in shipping: it sets yard workload years ahead and can support pricing when order slots tighten. It also cuts the other way fast when freight markets cool or owners struggle to finance deliveries. For Yangzijiang Shipbuilding, which sells capacity years into the future,
14 January 2026
···
BitMine (BMNR) stock barely budges after $5.2 billion quarterly loss as share-vote deadline nears

BitMine (BMNR) stock barely budges after $5.2 billion quarterly loss as share-vote deadline nears

New York, Jan 13, 2026, 21:27 EST — The market has closed. Shares of BitMine Immersion Technologies Inc barely budged Tuesday, edging up roughly 0.2% after the market closed. The company reported a quarterly net loss of $5.2 billion, largely due to an unrealized loss on digital assets amounting to $5.25 billion. Revenue climbed 91% to $2.3 million. As of Nov. 30, the filing revealed digital assets valued at $10.6 billion, with cash and cash equivalents near $888 million. The numbers are crucial since BitMine’s operating line is tiny compared to its crypto balance sheet. This shifts the stock’s narrative—and
14 January 2026
·····
Qualcomm stock slides again as traders size up handset risk ahead of Feb. 4 earnings

Qualcomm stock slides again as traders size up handset risk ahead of Feb. 4 earnings

New York, Jan 13, 2026, 19:47 (ET) — After-hours Qualcomm Incorporated shares dropped roughly 2.4% to $165.29 in after-hours trading Tuesday, extending the recent streak of declines for the stock. The pullback comes as investors adjust their bets on chip stocks tied heavily to handsets, a sector known for rapid demand shifts and volatile pricing. Qualcomm, meanwhile, faces pressure to demonstrate its growth extends beyond phones, but the market shows little tolerance when that story falters. Qualcomm will hold its fiscal first-quarter earnings call on Feb. 4. (investor.qualcomm.com) During the regular session, the stock dropped 2.35%, marking its third consecutive
14 January 2026
····
1 … 51 52 53 54 55 … 282

Stock Market Today

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

Nvidia stock jumps nearly 8% as Big Tech AI spending bets lift chipmakers and Dow tops 50,000

7 February 2026
Nvidia surged 7.8% Friday, leading a chip stock rally that pushed the Dow above 50,000 for the first time. The PHLX semiconductor index gained 5.7% as Advanced Micro Devices rose 8.3% and Broadcom 7.1%. Amazon fell 5.6% after projecting $200 billion in 2026 capital spending. Investors weighed a $600 billion AI infrastructure outlay against sharp losses in software shares.
Glencore share price steadies after Rio Tinto walks away — what to watch next week

Glencore share price steadies after Rio Tinto walks away — what to watch next week

7 February 2026
Glencore shares closed up 0.6% at 478.1 pence Friday, rebounding after a 7% drop following the collapse of merger talks with Rio Tinto. The company is expected to announce the sale of its Kazzinc stake soon and has signed a non-binding agreement with Orion for a potential $9 billion deal in the DRC. Investors await Glencore’s full-year results on Feb. 18 for further guidance.
Go toTop